Skip to Content

Logo (Actavis) 155 (Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base))

Pill imprint Logo (Actavis) 155 has been identified as Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base).

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual)
Imprint:
Logo (Actavis)
155
Strength:
8 mg (base) / 2 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Narcotic analgesic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Manufacturer:
Actavis Elizabeth LLC
National Drug Code (NDC):
00228-3155
Inactive Ingredients:
citric acid anhydrous
crospovidone
lactose monohydrate
magnesium stearate
mannitol
corn starch
povidone
sodium citrate
sucralose

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide